合成生物技术公司Twist Bioscience(TWST)周一盘前股价大涨17.92%,引发市场关注。
公司刚公布的第四财季财报好于预期,成为其股价上涨的主要推手。具体数据显示,TWST第四财季营收达8470万美元,超过分析师预期的8220万美元;净亏损为每股59美分,亦优于预期的每股亏损71美分。
值得一提的是,TWST还对2025财年全年营收给出了3.67亿至3.77亿美元的乐观预期,中值达3.714亿美元。公司同时预计2025财年第一季度营收约为8700万美元。TWST上佳的财报和积极前景预期,提振了投资者对该股的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.